Clinical Trial Update: Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial update on the immunogenicity of monovalent type 2 oral poliovirus vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Monovalent type 2 oral poliovirus vaccine

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Poliomyelitis | Phase 4 | Status: COMPLETED